Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

QuickTake: Sports, Cheating, and Anti-Doping Efforts
54:53 - In today’s “QuickTake,” Bloomberg's Vonnie Quinn takes a look at anti-doping efforts to clean up the Olympics and professional sports. She speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Apple and the Fed: The Week Ahead for ETFs
  • Politics and Markets: Preparing Your Portfolio
  • Yahoo CEO Marissa Mayer on Verizon Deal, Her Future